Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Knoll Capital Management, LLC | 5.48M | $9.0M | 9.08% | -- | 2026-03-31 |
| BlackRock, Inc. | 3.76M | $6.0M | 6.24% | -86.2K | 2026-03-31 |
| AQR CAPITAL MANAGEMENT LLC | 2.83M | $4.0M | 4.69% | +1.60M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.36M | $3.0M | 3.92% | -- | 2026-03-31 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2.15M | $3.0M | 3.57% | +302.3K | 2026-03-31 |
| 683 Capital Management, LLC | 1.50M | $2.0M | 2.49% | -30.0K | 2026-03-31 |
| D. E. Shaw & Co., Inc. | 1.40M | $2.0M | 2.33% | -197.3K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.25M | $2.0M | 2.07% | +81.1K | 2026-03-31 |
| ARDSLEY ADVISORY PARTNERS LP | 1.25M | $2.0M | 2.07% | -250.0K | 2026-03-31 |
| JANE STREET GROUP, LLC | 1.14M | $1.0M | 1.89% | +757.6K | 2026-03-31 |
